Projects Funded

Dr. Filipa Lynce at Dana-Farber Cancer Institute

$50,000 research grant awarded to Dr. Filipa Lynce at Dana-Farber Cancer Institute in support of her groundbreaking work investigating the T-cell receptor (TCR) clonotype repertoire in Inflammatory Breast Cancer (IBC) and its association with clinical outcomes. This important two-year project will receive $50,000 in funding this year, with a commitment for an additional $50,000 in the second year.

Dana Farber Cancer Institute

$5,000 Yearly matching grant for the annual Jimmy Fund Walk to support cancer research at Dana Farber Institute.

The James, The Ohio State University
Dr. Lori Gill-Grennan Inflammatory Breast Cancer Fund

This funding supports education, research, and clinical activities for inflammatory breast cancer and/or program promotion or operational costs related to the inflammatory breast cancer program at Ohio State University. The research funded under this effort is Dr. Daniel Stover.

Dana Farber Cancer Institute

$5,000 matching grant for the annual Jimmy Fund Walk to support cancer care and cancer research at Dana Farber Institute.

The University of Texas

The project will develop the first Breast-Skin microfluidic experimental platform to dynamically and spatially measure cancer cell invasion into the dermal layer, skin lymphatics, and breast vasculature characteristic of IBC. This platform will be employed to determine the cellular components and tissue properties that drive IBC cancer cell migration to enable development of potential treatments and preventive strategies.

The University of Texas

PhD. student conducting the research with Marissa N. Rylander, PhD. to develop the first Breast-Skin microfluidic experimental platform to dynamically and spatially measure cancer cell invasion into the dermal layer, skin lymphatics, and breast vasculature characteristic of IBC. This platform will be employed to determine the cellular components and tissue properties that drive IBC cancer cell migration to enable development of potential treatments and preventive strategies.

The University of Texas MD Anderson Cancer Center

Matching grant for this annual fundraiser that provides support for patient programs, research, prevention and education at MD Anderson — and 100% of funds raised by participants directly support MD Anderson’s mission to end cancer.